Technical Analysis for GRTS - Gritstone Oncology, Inc.

Grade Last Price % Change Price Change
C 2.47 3.78% 0.09
GRTS closed up 3.78 percent on Monday, March 18, 2024, on 73 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Wide Bands Range Expansion 0.00%
Crossed Above 20 DMA Bullish 3.78%
Wide Bands Range Expansion 3.78%
50 DMA Resistance Bearish 10.27%
Fell Below 20 DMA Bearish 10.27%
MACD Bearish Signal Line Cross Bearish 10.27%
Wide Bands Range Expansion 10.27%

   Recent Intraday Alerts

Alert Time
Up 5% about 9 hours ago
50 DMA Resistance about 11 hours ago
Up 3% about 12 hours ago
60 Minute Opening Range Breakout about 12 hours ago
Rose Above Previous Day's High about 12 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight multiple cancer types. The company has built its tumor-specific immunotherapy approach on two key pillars—first, a proprietary machine learning-based platform, Gritstone EDGE™, which provides a powerful ability to predict from a routine tumor biopsy the tumor-specific neoantigens, or TSNA, that are presented on a patient’s tumor cells; and second, the ability to develop and manufacture potent immunotherapies utilizing patients’ TSNA to drive the patient’s immune system to attack and destroy tumors.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Medicine Immune System Immunotherapy Oncology Tumor Cancer Immunotherapy Machine Learning Virotherapy Immunotherapies Biopsy Tumor Cell

Is GRTS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.33
52 Week Low 1.14
Average Volume 2,057,363
200-Day Moving Average 2.01
50-Day Moving Average 2.42
20-Day Moving Average 2.36
10-Day Moving Average 2.38
Average True Range 0.27
RSI (14) 52.61
ADX 17.59
+DI 28.46
-DI 20.07
Chandelier Exit (Long, 3 ATRs) 2.30
Chandelier Exit (Short, 3 ATRs) 2.65
Upper Bollinger Bands 2.87
Lower Bollinger Band 1.85
Percent B (%b) 0.6
BandWidth 43.14
MACD Line 0.02
MACD Signal Line 0.02
MACD Histogram 0.0035
Fundamentals Value
Market Cap 235.49 Million
Num Shares 95.3 Million
EPS -1.24
Price-to-Earnings (P/E) Ratio -1.99
Price-to-Sales 20.98
Price-to-Book 2.90
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.82
Resistance 3 (R3) 2.79 2.65 2.76
Resistance 2 (R2) 2.65 2.56 2.66 2.74
Resistance 1 (R1) 2.56 2.50 2.60 2.59 2.72
Pivot Point 2.42 2.42 2.44 2.43 2.42
Support 1 (S1) 2.33 2.33 2.37 2.36 2.22
Support 2 (S2) 2.19 2.27 2.20 2.20
Support 3 (S3) 2.10 2.19 2.18
Support 4 (S4) 2.13